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Deﬁning the virus–host interactions responsible for HIV-1 trans-
mission, including the phenotypic requirements of viruses capable
of establishing de novo infections, could be important for AIDS
vaccine development. Previous analyses have failed to identify
phenotypic properties other than chemokine receptor 5 (CCR5)
and CD4+ T-cell tropism that are preferentially associated with
viral transmission. However, most of these studies were limited
to examining envelope (Env) function in the context of pseudovi-
ruses. Here, we generated infectious molecular clones of transmitted
founder (TF; n = 27) and chronic control (CC; n = 14) viruses of
subtypes B (n = 18) and C (n = 23) and compared their phenotypic
properties in assays speciﬁcally designed to probe the earliest
stages of HIV-1 infection. We found that TF virions were 1.7-fold
more infectious (P = 0.049) and contained 1.9-fold more Env per
particle (P = 0.048) compared with CC viruses. TF viruses were also
captured by monocyte-derived dendritic cells 1.7-fold more efﬁ-
ciently (P = 0.035) and more readily transferred to CD4+ T cells
(P = 0.025). In primary CD4+ T cells, TF and CC viruses replicated
with comparable kinetics; however, when propagated in the pres-
ence of IFN-α, TF viruses replicated to higher titers than CC viruses.
This difference was signiﬁcant for subtype B (P = 0.000013) but not
subtype C (P= 0.53) viruses, possibly reﬂecting demographic differ-
ences of the respective patient cohorts. Together, these data in-
dicate that TF viruses are enriched for higher Env content,
enhanced cell-free infectivity, improved dendritic cell interaction,
and relative IFN-α resistance. These viral properties, which likely act
in concert, should be considered in the development and testing of
AIDS vaccines.
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Understanding the host and viral factors that inﬂuence theability of HIV-1 to cross mucosal barriers may be critical for
the development of an effective AIDS vaccine (1). HIV-1 virions
or infected cells are believed to cross the epithelium shortly after
sexual exposure, although the mechanisms by which this transfer
occurs remain largely unknown. Within the mucosa, viruses are
believed to interact with dendritic cells (DCs), such as Langer-
hans cells, but do not productively infect these cells (2). In the
simian model of HIV-1, the ﬁrst cells to become productively
infected are resting intraepithelial CD4+ T cells, which represent
the most abundant target cell type in the lamina propria (3).
Simultaneous with initial infection events, local innate immune
responses are elicited, with plasmacytoid DCs accumulating
rapidly at sites of virus entry. These cells secrete cytokines and
chemokines, such as macrophage inﬂammatory protein (MIP)1-β
and type I IFNs, and orchestrate an early local innate immune
response (4). After infection in mucosal and submucosal tissues
is established, HIV-1 spreads to regional and distant lymphoid
tissues, including the gut-associated lymphoid tissue, where virus
expands exponentially, triggering a systemic cytokine storm
preceding peak viremia (5, 6).
Many host factors can inﬂuence whether virus exposure leads
to productive infection, including the physical barrier of the
mucosa and its associated mucous secretions (7, 8), target cell
availability (9, 10), immune activation (11), genital inﬂammation
(12), and altered mucosal microbiota (13). Although chronic
HIV-1 infection is characterized by high genotypic and pheno-
typic diversity, the extent to which this variation inﬂuences the
transmission process remains unclear (14, 15). Transmission
across intact mucosal barriers is inherently inefﬁcient and in-
variably associated with a viral population bottleneck (1, 16).
Indeed, in 60–80% of mucosal infections, a single transmitted
founder (TF) virus is responsible for productive clinical infection
(16). This ﬁnding has raised the question of whether the trans-
mission process represents a stochastic event, in which every
replication-competent virus has an equal chance of establishing
a new infection, or whether the bottleneck selects for viruses that
exhibit particular biological properties that predispose them to
establish new infections more efﬁciently (14). In support of the
latter, transmitted viruses have generally been found to exhibit
chemokine receptor 5 (CCR5) tropism, infect CD4+ T cells but
not macrophages, and share certain genetic features, including
shorter variable loops, fewer potential N-linked glycosylation
sites, and amino acid signatures, which may affect envelope gly-
coprotein (Env) surface expression and/or other viral properties
(17–22). However, to date, no consistent phenotypic correlate of
these genetic signatures has been identiﬁed.
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Initial phenotypic studies of viruses obtained during acute and
early infection were limited to analyses of Env functions, which
were almost exclusively conducted in the context of pseudovi-
ruses. These analyses led to a number of hypotheses as to how
transmitted viruses might differ from their chronic counterparts,
including that they engage their receptor and/or coreceptor more
efﬁciently (23, 24), that they are more sensitive to neutralizing
antibodies (17, 25), and that their Env glycoproteins interact
preferentially with the integrin pair-α4β7 (26). However, most of
these studies used Envs obtained weeks or months postinfection
after substantial virus evolution and selection had already oc-
curred. We, thus, used single-genome ampliﬁcation and a model
of random virus evolution to generate Env clones corresponding
to actual TF genomes (16, 27). Although we conﬁrmed that TF
Envs use CCR5 as the coreceptor for entry, we failed to ﬁnd
evidence that TF Envs used CD4 and CCR5 particularly efﬁ-
ciently (28, 29), interacted speciﬁcally with α4β7 (29), or
exhibited a preferential tropism for particular CD4+ T-cell
subsets (28, 29). We also failed to identify an enhanced overall
sensitivity of TF Envs to neutralization, although subtype B TF
Envs were slightly more sensitive to CD4 binding site neutral-
izing antibodies than subtype C TF Envs (28). Most recently, we
discovered that TF Envs are more completely inhibited by
small-molecule CCR5 antagonists than control Env constructs,
suggesting differences in CCR5 interaction (30); however, the
biological relevance of this ﬁnding remains to be determined
(30). Thus, except for preferential CCR5 coreceptor use and
CD4+ T-cell tropism, no other reproducible phenotypic dif-
ference between TF and chronic viruses has been identiﬁed.
Env pseudotypes are generated by cotransfection of an env
expression cassette with an env-minus proviral backbone. Be-
cause this backbone represents a standard HIV-1 genome, the
contribution of gene products other than Env to the TF phe-
notype cannot be assessed. Moreover, overexpression of Env,
which is inherent in the cotransfection assay, precludes a mean-
ingful assessment of virus–host cell interactions and particle
composition. Reasoning that these shortcomings may have ob-
scured important biological differences, we developed methods
to clone full-length TF genomes and showed that these produced
replication-competent viruses (31–33). However, a systematic
evaluation of the TF phenotype also required a sufﬁcient number
of molecularly cloned chronic control (CC) viruses for compar-
ison. Here, we describe the generation and biological charac-
terization of a comprehensive panel of TF (n = 27) and CC (n =
14) infectious molecular clones (IMCs), representing two major
group M subtypes. Using these reagents, we compared biological
properties that would be expected to inﬂuence viral ﬁtness dur-
ing the earliest stages of the transmission process. Our results
reveal that TF viruses share common traits that likely enhance
their ﬁtness in crossing mucosal surfaces and promoting the es-
tablishment of a productive initial infection.
Results
IMCs of TF and CC Viruses. Although a limited number of TF and
CC IMCs has previously been reported (29, 31–33), available
clones, especially from chronically infected individuals, were too
few to conduct meaningful phenotypic comparisons (29). To
create a more balanced panel, with respect to both the number of
TF and CC IMCs and their subtype representation, we cloned
additional viral genomes from individuals enrolled in acute and
chronic HIV-1 infection cohorts. Using previously reported
methods (31–33), we inferred 12 additional TF genomes (Fig. S1)
representing mucosally transmitted viruses from single (n = 8)
and multivariant (n = 4) infections. Together with existing con-
structs, these clones comprised a panel of 27 TF IMCs, with equal
representation of subtypes B (n = 13) and C (n = 14) viruses
(Table S1).
Chronically HIV-1–infected individuals harbor complex qua-
sispecies of genetically diverse HIV-1 variants. Because it is
impossible to predict based on sequence inspection alone which
variants are biologically active and which variants are function-
ally impaired, we ampliﬁed between 20 and 40 env genes or 3′
half-genomes from chronic infection plasmas and searched for
clusters of nearly identical sequences as indicators of recent
clonal expansions (Fig. S2). We reasoned that the inferred
common ancestors of these clusters must encode persistently
replicating viruses and thus, represent relevant controls for bi-
ological comparisons with TF viruses. Consistent with this in-
terpretation, we found that all chronic IMCs generated from
such expansion rakes produced viruses that grew to high titers in
CD4+ T cells. However, not all chronic infection plasmas were
suitable for IMC construction. Analyzing specimens from over 60
individuals, we identiﬁed only 14, including 4 reported previously
(29), that exhibited clonal expansion rakes in both 3′ and 5′
halves of their viral genomes (Fig. S2). These chronic plasma
samples were used to construct CC IMCs representing both
subtypes B (n = 5) and C (n = 9) infections (Table S1).
To determine the coreceptor use of 22 newly derived IMCs, we
infected CCR5- and CXC chemokine receptor type 4 (CXCR4)-
expressing reporter cells in both the presence and absence of their
respective inhibitors (16). Consistent with previous analyses of Env
pseudotypes (16, 28, 29, 34), the results indicated that all IMCs
were CCR5 tropic, except for one TF and twoCC viruses that were
dual tropic for CCR and CXCR4 (Table S1).
Phenotypic Studies. All biological experiments were performed
using viral stocks that were CD4+ T cell-derived, sucrose-puriﬁed,
and depleted of CD45+ microvesicles. Virus was quantiﬁed by
measuring reverse transcriptase (RT) activity, viral RNA copy
number, and Gag p24 antigen content. Comparing these values,
we noticed that subtype C stocks seemed to contain about ﬁve-
fold less p24 antigen per unit of RT activity than subtype B
stocks (Fig. S3A). This discrepancy was also seen when p24
antigen was normalized using RNA copy numbers (Fig. S3B).
However, no such difference was observed when virion RT ac-
tivity was compared with RNA copy number (Fig. S3 C and D).
Similar results were obtained when viral stocks were tested in
two additional p24 detection assays (Fig. S3 E and F). Thus,
three commonly used p24 capture assays bound subtype C core
proteins considerably less efﬁciently than subtype B core pro-
teins, leading to a systematic underestimation of the number of
viral particles in subtype C viral stocks. We, therefore, used RT
activity to normalize virus input and measure virus replication in
all subsequent experiments.
To determine whether TF and CC viruses differed in their
phenotypic properties, we used two complementary statistical
approaches. First, we used a conservative nonparametric per-
mutation test (perm test) to address the central question of
whether TF and CC viruses exhibited reproducible phenotypic
differences. Second, we used a generalized linear model (GLM)
to test for interactions between different parameters, such as
subtype and cell donors in replicate experiments, and test for the
independence of viruses from the same subjects. Because both
virus status (TF or CC) and subtype (B or C) inﬂuenced the
biological outcome, the GLM test allowed us to interpret the
data with these variables taken into account.
TF Viruses Exhibit Enhanced Infectivity. Plasma virus collected
during ramp-up stages of acute simian immunodeﬁciency virus
(SIV) infection has been shown to be signiﬁcantly more infectious
than virus collected from later plasma samples (35). To examine
whether this observation was also true for HIV-1, we used
a single-round infection assay to determine whether TF virions
were more infectious on a per-particle basis than CC virions.
Serial dilutions of CD4+ T cell-derived viral stocks were used
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to infect TZM-bl cells (which express luciferase under the control
of an HIV-1 promoter), and the resulting relative light units were
expressed as a function of the input RT activity. The results
showed that TF viruses as a group were 1.7-fold more infectious
than CC viruses (Fig. 1A), although this difference was only
marginally signiﬁcant (P= 0.049 by perm test; P= 0.062 byGLM).
Similar results were obtained when subtypes B and C viruses were
considered separately (there was no subtype dependence of in-
fectivity) (Fig. 1B). To enhance virus infectivity, we repeated these
experiments in the presence of diethylaminoethyl (DEAE) dex-
tran, which is known to increase virus attachment to target cells
(36). As expected, DEAE dextran increased the per-particle in-
fectivity of all viruses by up to three orders of magnitude (Fig.
1C), with a signiﬁcantly greater effect on subtype C than subtype
B virions (P = 0.015 by GLM) (Fig. 1D). However, in the presence
of DEAE dextran, the marginally signiﬁcant difference between
TF and CC viruses shifted to nonsigniﬁcance (P = 0.068 by perm
test; 0.083 by GLM). Taken together, these data indicate that
TF viruses are, on average, nearly two times as infectious as
viruses that persist during chronic infection. However, when
normal barriers to cell-free infection are mitigated by DEAE
dextran, this difference is no longer signiﬁcant (although a trend
was still evident).
TF Virions Have a Higher Env Content. Previous computational
analyses of TF and CC env gene sequences revealed genetic
signatures in TF viruses that increased Env expression and par-
ticle incorporation when tested in the context of pseudoviruses
(37). We, thus, examined whether TF virions packaged more Env
per particle than CC virions. To detect both subtypes B and C
Env proteins with comparable efﬁciency, we developed an
ELISA that used antibodies previously shown to bind genetically
highly diverse envelope (gp120) proteins. To capture Env, we
used CD4-218.3-E51, a chimeric antibody that contains the ﬁrst
and second domains of human CD4 linked to the CD4-induced
monoclonal E51 (38). To detect bound Env, we selected afﬁnity-
puriﬁed anti-gp120–speciﬁc polyclonal antibodies that were iso-
lated from human plasma (Advanced Bioscience Laboratories,
Inc.). Using this ELISA, we found that TF viruses contained 1.9
times more Env per unit of RT activity than CC viruses (P =
0.048 by perm test; P = 0.057 by GLM) (Fig. 1E). Subtype B
viruses appeared to package 2.4-fold more Env per particle than
subtype C viruses (Fig. 1F), but this result was largely caused by
a binding preference of the capture antibody, which recognized
subtype B Env glycoproteins two times more efﬁciently than
subtype C Env glycoproteins. Nonetheless, this subtype bias did
not affect the differential between TF and CC viruses, which was
seen for both subtypes B and C, and it was controlled for in the
statistical analyses (Fig. 1F). As expected, there also was a sig-
niﬁcant correlation between Env content and particle infectivity
(r = 0.33; P = 0.036).
TF Viruses Bind DCs More Efﬁciently. DCs have been proposed to
play an important role in HIV-1 transmission, because they are
located in the mucosa (39, 40), capture viruses using lectins (41,
42) and glycosphingolipid receptors (43), and efﬁciently transmit
infectious particles to CD4+ T cells (44–46). To examine
whether TF and CC viruses differ in their ability to bind DCs, we
pulsed immature monocyte-derived DCs (moDCs) with equal
amounts of virus (normalized by RT activity), washed the cells
extensively to remove cell-free virions, and then lysed the cells to
quantify the amount of cell-associated virus. Using cells from
three different donors (Fig. 2A), we found that moDCs captured
TF viruses 1.6 times more efﬁciently than CC viruses (P = 0.040
by perm test; P = 0.060 by GLM). This increase was observed for
both subtypes B and C TF viruses (Fig. 2B), although subtype B
viruses were captured 3.4 times more efﬁciently than subtype C
viruses (P = 4.6 × 10−6 by GLM) (Fig. 2B).
Because in the above experiment, we had normalized virus
input by RT activity but measured virion capture using the more
sensitive p24 assay, we considered the possibility that the
subtype-speciﬁc differences were an artifact of the p24 antigen
capture assay. To explore this possibility, we repeated the bind-
ing experiment with cells from three additional donors, but this
time, we normalized virus input by p24 content (Fig. 2 C and D).
Despite adding an estimated ﬁvefold excess of subtype C virions,
TF viruses were again captured 1.8 times more efﬁciently than
CC viruses (P = 0.030 by perm test; P = 0.014 by GLM).
Moreover, there was still a subtype-speciﬁc difference, with
subtype B viruses being captured 1.9 times more efﬁciently than
subtype C viruses (P = 0.0029 by GLM). As a control, we treated
an aliquot of the pulsed moDCs with 0.25% trypsin-EDTA
and showed that this treatment removed all detectable cell-
associated virus, conﬁrming that most of the DC-associated virus
was surface-exposed (47). We also cultured virus-exposed moDCs
and showed that these cells were not productively infected. Fi-
nally, we asked whether the percentage of captured virus for
each strain correlated between different donors. This association
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Fig. 1. Virion infectivity and Env content. (A–D) Infectivity values for TF and CC viruses (x axis) are expressed as relative light units (RLUs) per picogram of viral
RT activity (y axis). (A) Bars indicate the median infectivity of TF (ﬁlled) and CC (open) viruses, with interquartile ranges indicated. TF viruses were 1.7-fold
more infectious than CC viruses (P = 0.049). (B) Infectivity values are shown for each virus. Subtypes B and C viruses are shown in red and blue, respectively,
with TF viruses indicated in dark colors and CC viruses indicated in light colors, respectively. Values represent averages from four independent experiments. (C
and D) Infectivity values are shown for TF and CC viruses as in A and B, except that infections were performed in the presence of DEAE dextran. Values
represent averages from three independent experiments. (E and F) Env content of TF and CC virions (x axis) is expressed as the mass ratio of Env and RT
content (y axis). (E) Bars indicate the median values of Env content for TF (ﬁlled) and CC (open) viruses, with interquartile ranges indicated. TF viruses
contained 1.9 times more Env per unit of RT activity than CC viruses (P = 0.048). (F) Env content is shown for each virus and color-coded as in B and D. Values
represent averages from two independent experiments.
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was indeed observed regardless of whether virus input was nor-
malized by RT activity or p24 content, thus validating the DC
binding assay (Fig. S4A).
Although the combined data from all six donors indicated that
DCs captured TF viruses 1.7-fold more efﬁciently than CC
viruses (P = 0.035 by perm test; P = 0.005 by GLM), there was
considerable donor variability, with moDCs from two donors (A
and F in Fig. 2) failing to yield signiﬁcant binding differences
(Fig. S4). To examine potential reasons, we compared surface
expression levels of DC-speciﬁc intracellular adhesion molecule
3-grabbing nonintegrin (DC-SIGN) and macrophage mannose
receptor (MMR) by ﬂow cytometry. Interestingly, moDCs of
donors A and F expressed lower levels of these molecules (Fig.
S4 B and C), suggesting that the number of Env-speciﬁc binding
sites on their cells was limited. For the remaining four donors,
moDC virus capture tended to correlate with particle Env con-
tent (Fig. S4D). These data suggest that virion Env content
represents one important determinant in moDCs binding, al-
though expression of lectins and other factors clearly also play
a role (48).
To examine the efﬁciency of virus transfer from moDC to
CD4+ T cells, we pulsed moDCs with equivalent amounts of TF
and CC viruses, cocultured these cells with autologous CD4+
T cells, and then measured RT activity in culture supernatants as
an indicator of virus replication. Analysis of cells from two different
donors showed that TF viruses replicated to slightly higher titers
than CC viruses each day over the course of 10 d (one represen-
tative donor is shown in Fig. 3). Although these differences were
not signiﬁcant in the perm test (P = 0.104), signiﬁcant differences
in TF and CC virus titers were observed in the GLM analysis (P =
0.025). To explore the reason for this apparent discordance, we ran
the perm test on subtypes B and C viruses separately (Fig. 3B), and
we found that subtype B TF viruses (P = 0.004), but not subtype
C TF viruses (P = 0.23), grew to signiﬁcantly higher titers than their
respective chronic controls. Averaging data from both donors and
across all time points, this difference was 11.2-fold for subtype
B viruses but not signiﬁcant for subtype C viruses. Because subtype
B virions bound moDCs 3.5-fold more efﬁciently than subtype C
viruses (Fig. 2 B and D), we interpret these ﬁndings to indicate that
virions that bind moDCs more efﬁciently are also transferred to
CD4+ T cells more efﬁciently.
TF Viruses Are Relatively More Resistant to IFN-α. CD4+ T cells
represent the predominant target cells in gut-associated lym-
phoid tissues and the ﬁrst cell type to become productively
infected after transmission (49). To determine the growth po-
tential of TF and CC viruses in this cell type, we infected acti-
vated CD4+ T cells from three healthy donors with equivalent
amounts of virus and monitored viral growth by measuring RT
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viruses were captured 3.4 times more efﬁciently than subtype C viruses (P = 4.6 × 10−6 by GLM).
Day
2 4 6 8 10
2 4 6 8 10
Day
pg
R
T
ac
tiv
ity
pg
R
T
ac
tiv
ity
102
104
100
100
106
102
104
A
B
Fig. 3. DC-mediated trans infection. (A) Virus replication expressed as
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higher titers than subtype B CC viruses (P = 0.004), whereas no signiﬁcant
differences were observed for subtype C TF and CC viruses (P = 0.23).
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activity in culture supernatants (Fig. 4 A, C, and E, gray lines).
Although TF viruses replicated to slightly higher titers, especially
at the earliest time point postinfection, this difference was not
statistically signiﬁcant (P = 0.16 by perm test; P = 0.186 by
GLM). Thus, in activated CD4+ T cells, TF and CC viruses
replicated with comparable efﬁciency.
IFN-α is produced early in infection by plasmacytoid DCs (50),
which are among the ﬁrst cells to be recruited to the mucosal site
of virus entry (4). This cytokine stimulates expression of hun-
dreds of host genes [IFN-stimulated genes (ISGs)] (51), many of
which have anti–HIV-1 activity (52). IFN-α has also been shown
to limit Env incorporation into virus particles that are released
from infected CD4+ T cells (53). To determine the sensitivity of
TF and CC viruses to the antiviral activity of this cytokine, we
analyzed their replication kinetics in CD4+ T cells in the pres-
ence of 500 U/mL IFN-α. Determining RT activity in culture
supernatants as a measure of viral replication, we found signiﬁ-
cant differences in the growth rate of TF and CC viruses (Fig. 4
A, C, and E, black lines). However, this effect was highly subtype-
speciﬁc (Fig. S5). Averaging replication data from all donors and
across all time points, we found that subtype B TF viruses grew
to 62-fold higher titers than subtype B CC viruses (P = 0.000013
by GLM). In contrast, subtype C TF viruses grew only 1.7-fold
more efﬁciently than their respective CC viruses, which was not
signiﬁcant (P = 0.53 by GLM). Importantly, this difference was
not because of a lack of IFN-α resistance of the subtype C TF
viruses but an increased IFN-α resistance of the respective
chronic controls (Fig. 4 B, D, and F). Inclusion of sex and risk
group information into the statistical analyses indicated that
neither was signiﬁcantly associated with IFN-α resistance; how-
ever, the study was not sufﬁciently powered to examine the im-
pact of sex and risk group, and a contribution of these factors
cannot, therefore, be excluded (Fig. S5).
As a different way to analyze these data, we also calculated the
ratio of virus production in the presence and absence of IFN-α
for each virus strain (Fig. 4 B, D, and F). Comparing across all
donors, we again found that TF viruses were signiﬁcantly more
resistant to inhibition by IFN-α than chronic viruses (P = 0.027
by perm test). However, when considering the two clades sepa-
rately, this ﬁnding was signiﬁcant only for subtype B (P = 0.0004
by one-sided Wilcoxon test) and not for subtype C (P = 0.84).
Viruses that were highly resistant in one donor were also highly
resistant in the other donors (Fig. S6), indicating that their IFN-α
phenotype was consistent between donors.
To determine whether the higher titers of TF viruses were
because of increased particle release or differences in viral
spread, we used ﬂow cytometry to measure the percent of
infected cells in IFN-α–treated cultures from two donors (Fig.
S7). In the presence of IFN-α, TF viruses infected a larger
number of cells than CC viruses, although the overall effect was
only marginally signiﬁcant (P = 0.049 by perm test). However,
GLM analysis again detected a signiﬁcant interaction between
subtype and TF/CC status (P = 0.041), indicating that the dif-
ferences were primarily caused by subtype B viruses. Because the
ratio of virus production in the presence and absence of IFN-α
correlated well with the percent of Gag-positive cells (P <
0.0001) (Fig. S7 B and C), it is likely that IFN-α resistance rep-
resents an enhanced ability to spread between CD4+ T cells.
Interestingly, this phenotype correlated only weakly with particle
infectivity and Env content, indicating that the higher levels of
particle-associated Env in TF viruses are not the main drivers of
their relative IFN-α resistance.
Discussion
A primary goal of AIDS vaccine development is to prevent ac-
quisition of HIV-1 at mucosal surfaces. In this context, it is
critical to determine whether newly transmitted HIV-1 strains
share traits that provide novel targets for effective immunization.
For such an analysis, the use of full-length IMCs is essential,
because they contain the complete genetic information of viruses
that successfully transmit infection. Moreover, genetic linkage is
maintained to preserve potentially important regulatory and
structural protein interactions (16, 31–33). Characterizing a large
set of TF and CC IMCs from two major HIV-1 group M sub-
types, we found that TF viruses were slightly more infectious
than CC viruses on a per particle basis, packaged slightly more
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Fig. 4. Virus replication in CD4+ T cells in the presence and absence of IFN-α. (A, C, and E) The replication kinetics of TF (solid lines) and CC (broken lines)
viruses are shown in CD4+ T cells from three donors in the absence (gray lines) and presence (black lines) of 500 U IFN-α. RT activity indicated as picograms per
milliliter of culture supernatant (y axis) was measured every 3 d (x axis). Data points indicate median values of virus production, with interquartile ranges
indicated. Averaging data from all donors and points, TF viruses grew to 24-fold higher titers than CC viruses in the presence of IFN-α (P = 0.012). (B, D, and F)
The ratio of virus production in the presence and absence of IFN-α is plotted for each virus (y axis) at different time points (days) postinfection (x axis; color-
coding for TF and CC viruses from subtypes B and C as in Fig. 1). Averaging data from all donors, subtype B TF viruses grew to 62-fold higher titers than
subtype B CC viruses (P = 0.000013), whereas subtype C TF viruses grew only 1.7-fold more efﬁciently than subtype C CC viruses (P = 0.53). Note that these
replication differentials represent cumulative totals for the 12-d culture period.
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Env, bound to moDCs more efﬁciently, and were relatively more
resistant to the antiviral effects of IFN-α. These biological dif-
ferences could act in concert to enhance cell-free infection and
virus replication in the face of an early innate immune response.
Analyzing particle composition and infectivity, we found that
TF virions were, on average, two times as infectious and con-
tained two times as much Env as CC virions. These phenotypic
differences are consistent with data from a recent genetic study
(22) that identiﬁed sequence signatures in the signal peptide of
TF Env sequences. When tested in the context of pseudoviruses,
these signatures increased steady-state Env expression and par-
ticle incorporation (37). Assuming 35 enzymatically active RT
dimers per virion, we estimate that the median TF virion con-
tains 18 Env trimer spikes, whereas the median CC virion con-
tains 7 spikes, a value essentially identical to previous estimates
(54). Because only one or a few functional Env trimers are be-
lieved to be necessary for cell fusion and infection (55), it would
seem that TF viruses carry an excess of envelope glycoprotein.
Such excess is likely of advantage during the earliest stages of
HIV-1 infection, because viruses with a higher Env content may
also contain more functional trimers. Particle-associated Env
may also play a role beyond the mere fusion and cell entry
function. For example, excess Env could ensure more stable at-
tachment of virions to target cells and/or be involved in receptor
and/or coreceptor mediated signaling (56). In addition, excess
Env may compensate for shedding or inactivation by semen (57)
and cervicovaginal mucous (58). Thus, it seems likely that the
increased Env content and associated enhanced infectivity of TF
viruses serve to increase their transmission ﬁtness. Conversely,
the lower Env content of CC viruses may be more advantageous
after infection is established and may even be selected for by
Env-speciﬁc neutralizing antibodies.
We also found that TF viruses bind more efﬁciently to moDCs
than their chronic counterparts. Although moDCs are only
a proxy for mucosal DC subsets, previous studies have shown
that tissue- and in vitro-derived DCs have similar virus capture
capabilities (59, 60). Thus, it is likely that the improved in-
teraction of TF viruses with tissue culture-derived moDCs is also
a reﬂection of their in vivo biological properties. The differential
binding of TF viruses was statistically signiﬁcant across different
donors and across both clades, and thus, it seems to represent
a general feature of TF viruses. There are at least two steps in
the transmission process where this phenotype may confer an
advantage. First, more efﬁcient binding to tissue resident DCs
may increase the likelihood of a successful transfer to CD4+ T
cells. Second, more efﬁcient binding to emigrating DCs may
promote the seeding of regional lymph nodes (61). In this con-
text, it is of interest that adaptive changes that conferred mucosal
transmissibility to a commonly used simian-human immunode-
ﬁciency virus (SHIV-SF162P3) increased the binding capacity
of its Env glycoprotein to DC-SIGN (62). Our data are, thus,
consistent with the view that DCs are among the ﬁrst cells to
interact with HIV-1 after exposure and that this interaction is
important for transmission, although DCs themselves are not
productively infected.
One unexpected ﬁnding was that TF viruses replicated and
spread in CD4+ T cells in the presence of IFN-α more efﬁciently
than CC viruses. Although this effect was most pronounced for
subtype B TF viruses, a trend was also observed for subtype C TF
viruses. This ﬁnding raises the question of whether IFN-α
responses in the mucosa are protective against HIV-1 infection.
On ﬁrst glance, a review of the literature would suggest that the
answer to this question is no. Previous studies in macaques
concluded that the initial innate immune response is ineffective
at containing SIV infection and may even enhance early viral
replication (4). Moreover, mucosal pretreatment with toll-like
receptor agonists induced IFN-α but did not protect animals
from SIV challenge (63). However, these studies were not only
assessing the effects of IFN-α but also causing immune activation
by inducing proinﬂammatory cytokines and chemokines. In fact,
it has been shown more recently that blockade of type 1 IFN
during acute SIV infection resulted in accelerated progression to
AIDS and death (64). It, thus, seems that early IFN responses
can be protective against HIV-1/SIV infection. The fact that
IFN-α levels (65) as well as IFN regulatory factor polymorphisms
(66) have been associated with protection in highly exposed but
uninfected individuals is consistent with this hypothesis. Thus,
the induction of an effective early antiviral state seems to con-
tribute to the population bottleneck associated with mucosal
HIV-1 transmission.
We hypothesized that virions containing more Env would be
more resistant to IFN-α, because in previous studies, this cy-
tokine was reported to decrease cell-free virus transmission
(67), particle release (68), and particle infectivity (53). How-
ever, we failed to see a signiﬁcant correlation between IFN-α
resistance and Env content or virion infectivity. Thus, higher
baseline Env incorporation cannot explain the IFN-α–resistant
phenotype of TF viruses. Nonetheless, the ability of TF viruses
to replicate in the presence of IFN-α indicates that resistance-
conferring determinants must exist. There are several candi-
dates, such as the accessory proteins Vpu and Vif, that are
known to counteract the IFN-stimulated genes tetherin and
apolipoprotein B mRNA editing enzyme catalytic polypeptide-
like 3G (APOBEC3G), respectively (69, 70), as well as the Tat
protein, which has been reported to modulate the IFN-induced
RNase L antiviral pathway (71) and down-regulate the ISG
protein kinase R (72). Structural proteins, such as Gag, may
also contribute to IFN-α resistance by exhibiting differential
sensitivity to the tripartite motif family of proteins (73–75).
Finally, IFN-α resistance may not only be protein-mediated,
because variation in the number of transcription factor binding
sites in the long terminal repeat (LTR) region could also in-
ﬂuence IFN-α sensitivity (76, 77). Notably, there is a relation-
ship between IFN-α resistance and efﬁciency of transmission in
other viruses, including Venezuelan Equine Encephalitis virus
(78) and Bovine Viral Diarrhea Virus (79), suggesting that in-
creased IFN-α resistance may be a general property of trans-
mitted founder viruses.
If IFN-α resistance was a prerequisite for efﬁcient HIV-1
transmission, one would expect this viral property to be con-
served across all clades. The lack of signiﬁcance between subtype
C TF and CC viruses seems to argue against this conclusion;
however, Fig. 4 shows that the lack of signiﬁcance is not caused
by a loss of IFN-α resistance of subtype C TF viruses. Instead,
the 62-fold cumulative replication differential observed for sub-
type B viruses reﬂects a much greater IFN-α sensitivity of the
respective chronic controls. Although our panel of TF and CC
IMCs is much larger than any previously tested, there are epi-
demiological differences between the patient cohorts from which
they were derived. For example, all but one of the chronic sub-
type B IMCs were derived from men who had sex with men,
whereas seven of eight chronic subtype C IMCs were derived
from heterosexual women (Table S1). This sex bias may have
contributed to the increased IFN-α resistance of chronic subtype
C viruses, because plasmacytoid dendritic cells (pDCs) of women
have been reported to generate more IFN-α in response to HIV-1
than pDCs of men (80). In addition, all subtype C viruses were
derived from individuals living in Africa, whereas all subtype B
viruses were derived from patients residing in the United States
(Table S1). Thus, environmental factors, such as concurrent
infections that increase general inﬂammation levels, may have
selected for the much higher IFN-α resistance of the respective
chronic viruses. Finally, if loss of IFN-α resistance is the result of
pressure from host adaptive responses, then duration of infection
may have been an important variable. We have recently found
that subtype B viral isolates obtained from subjects later in infection
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are more sensitive to IFN-α than the viruses isolated shortly after
transmission. Thus, it seems clear that, to decipher the reasons
for the IFN-α resistance differences observed here, future studies
will need to consider patient demographics, route of trans-
mission, and duration of infection in addition to TF and CC virus
status. Such studies may also shed light on factors that fuel the
HIV-1 epidemic in Africa.
One of the motivations to characterize the phenotypic prop-
erties of TF viruses is the possibility that virus traits might be
uncovered that could represent useful vaccine targets. In this
context, the increased Env content of TF viruses may increase
their sensitivity to neutralization by allowing antibodies to bind
bivalently and potentially cross-link more densely packed Env
spikes (81). Similarly, the identiﬁcation of key ISGs that con-
tribute signiﬁcantly to viral control during the most vulnerable
stages of HIV-1 infection may provide a new vaccination strat-
egy, by either vaccine vector-mediated type I IFN production
and/or induction of T cells that express the antiviral ISGs.
The molecular identiﬁcation and biological analysis of TF viral
genomes are powerful enabling tools for characterizing the
transmission requirements and subsequent evolution of HIV-1,
SIV, and other viruses (16, 31–33, 82). In the present study, we
used TF analyses to characterize the biological properties of full-
length HIV-1 genomes captured at the moment of transmission.
Although we identiﬁed signiﬁcant phenotypic differences, none
of these differences completely differentiated TF from CC
viruses, and the magnitude of the observed differences was gen-
erally modest. This ﬁnding is not surprising, because TF viruses,
by necessity, represent a subset of a much larger and more diverse
set of viruses that replicates persistently throughout chronic in-
fection. We speculate that the viral population bottleneck asso-
ciated with mucosal transmission is largely caused by inherent
physical barriers but also speciﬁc virus–host cell interactions
necessary for early virus infection and replication, each of which
may pose hurdles to virus acquisition. Thus, even slight advan-
tages of TF viruses at one or more of these biophysical check-
points could signiﬁcantly increase their transmission ﬁtness.
Deﬁning the viral determinants that underlie this ﬁtness will
provide additional insights into the biology of mucosal HIV-1
transmission and may also inform vaccine design.
Materials and Methods
IMC Construction. The sequences of full-length TF and CC viruses were inferred
and molecularly cloned as described (27, 29, 31–33). GenBank accession
numbers are listed in Table S2.
Viral Stocks. CD4+ T cells pooled from nine donors were infected with 293T
cell-derived transfection supernatants. Viral stocks were harvested after 11 d
and depleted of CD45+ microvesicles. Viral p24 core protein content was
measured using the PerkinElmer High-Sensitivity AlphaLISA, the PerkinElmer
Alliance ELISA, and the method described by Biancotto et al. (83). RT activity
was measured using the Roche Reverse Transcriptase Assay. Viral RNA was
quantiﬁed using the Roche COBAS AmpliPrep/COBAS Taqman HIV-1 v.
2.0 Test.
Phenotypic Analyses. Coreceptor use was determined as described (33). Virion
infectivity was measured using the TZM-bl reporter cell line. Particle-
associated Env content was measured using a newly developed ELISA (SI
Materials and Methods). To assess DC capture and CD4+ T-cell transfer,
peripheral blood monocytes were differentiated to moDCs using 100 IU/mL
granulocyte-macrophage colony-stimulating factor (GM-CSF) and 200 IU/mL
IL-4. For moDC capture experiments, 1 × 105 cells were incubated with viral
stocks containing either 30 pg RT activity or 600 pg p24 protein. For CD4+
T-cell transfer experiments, viral stocks containing 50 pg RT activity were
added, and moDCs were cultured at a 1:5 ratio with autologous CD4+
T cells. For CD4+ T-cell infection studies, 2 × 106 negatively selected CD4+
T cells were infected overnight with viral stocks containing 30 pg RT activity.
Cells were then propagated in media containing 30 U/mL IL-2 in the presence
and absence of 500 U/mL IFN-α. Infected cells were identiﬁed by ﬂow
cytometry (SI Materials and Methods).
Statistical Analyses.Data were analyzed using a nonparametric perm test that
controlled for virus subtype, donor cells, and time of sampling as well as
a GLM that tested for interactions between and the relative importance of
these variables (SI Materials and Methods).
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